Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Integrated Solution for Diabetes Testing Is Efficient

By HospiMedica staff writers
Posted on 28 Aug 2007
Clinical laboratories will be provided with an integrated system for diabetes testing that automates sample processing, eliminates sample splitting, and improves operating efficiency while reducing costs and errors.

Sysmex America, Inc. More...
(Mundelein, IL, USA) and Bio-Rad Laboratories, Inc. (Hercules, CA, USA) have entered into a non-exclusive, multi-year distribution agreement to jointly market their complementary products with the aim of improving the efficiency and quality of diabetes testing. Sysmex will add Bio-Rad's diabetes testing method to the Sysmex HST-N automation line. Bio-Rad will supply their Variant II turbo link. Sysmex and Bio-Rad will work together to provide seamless service, training, installation, and customer support services.

Bio-Rad's hemoglobin A1c (A1C) blood test measures the amount of glucose attached to the hemoglobin in the red blood cell. This provides an estimate of how well blood glucose levels have been controlled during the previous three to four months. Bio-Rad's test is the industry's gold standard technology for determining whether a patient's diabetes is under control.

We are delighted to continue our long-standing history with Bio-Rad Laboratories, said John Kershaw, president, Sysmex America. The Bio-Rad Variant II turbo link is a perfect complement to the Sysmex HST-N hematology automation line. With the addition of A1c to our automation line, we can truly manage all the testing of the lavender top hematology sample tubes in the laboratory. Sysmex's lavender top management system provides hematology laboratories with the ability to conduct analysis of 90% of tests compatible with EDTA samples, such as complete blood count (CBC), Clostridium difficile, erythrocyte sedimentation rate (ESR), and A1c.

We are pleased to work with Sysmex in offering this integrated testing solution to clinical laboratories as it will enable them to provide superior diabetes testing services to doctors and their patients throughout the United States, said John Goetz, Bio-Rad vice president and group manager of clinical diagnostics.


Related Links:
Sysmex America
Bio-Rad Laboratories

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.